Claim Rates ID'd for Musculoskeletal Disorders From Overexertion
FRIDAY, April 23, 2021 -- The rate of work-related musculoskeletal disorder (WMSD) claims from overexertion among construction workers is highest for those aged 35 to 44 years, although the severity of WMSDs increases with age, according to research published in the April 23 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Harpriya Kaur, Ph.D., from the CDC in Atlanta, and colleagues analyzed the rate and cost of WMSD claims from overexertion among Ohio construction workers during 2007 to 2017. The rates and costs of allowed claims were assessed by age group.
The researchers found that the highest claim rate was experienced by workers aged 35 to 44 years: 63 per 10,000 full-time employees for WMSDs from overexertion compared with 59.6 and 55.5 for those aged 45 to 54 years and 25 to 34 years, respectively. On average, claims by workers aged 45 to 54 years and 55 to 64 years were more costly, and they resulted in more days away from work. To ensure that the majority of construction workers can safely perform jobs throughout their careers, ergonomic design improvements and interventions are needed.
"As age increases, the severity of WMSDs appears to rise, and the relative frequencies of WMSD types change," the authors write. "This suggests the potential usefulness of targeting some prevention efforts specifically to the needs of older workers."
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
TUESDAY, April 20, 2021 -- About 20 percent of U.S. adults experience chronic pain, according to a study published online April 2 in PAIN. Robert J. Yong, M.D., M.B.A., from...
TUESDAY, April 6, 2021 -- Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors, according...
WEDNESDAY, March 10, 2021 -- For individuals who reported muscle symptoms when taking statins, atorvastatin has no effect on muscle symptoms compared with placebo, according to...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.